Interferons and multiple sclerosis: is it plausible that beta-IFN treatment could influence the risk of cancer among MS patients?
Kingwell
Elaine
E
Tremlett
Helen
H
D015897:Comorbidity; D019317:Evidence-Based Medicine / Q000639:trends*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use*; D008954:Models, Biological; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000453:epidemiology*; D009369:Neoplasms / Q000453:epidemiology*; D018570:Risk Assessment
D007155:Immunologic Factors; D016899:Interferon-beta